small molecule

AMINOCAPROIC ACID

AMINOCAPROIC ACID

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameAMINOCAPROIC ACID
Active ingredientAMINOCAPROIC ACID
Strength0.25GM/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2019
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.